Actively Recruiting
Can Complex Carbohydrates and Essential Amino Acid Supplementation Improve Outcomes Following Geriatric Hip Fractures
Led by NYU Langone Health · Updated on 2026-03-03
118
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the effects of a commercially available peri-operative nutritional supplement called XR Recovery on muscle loss in older adults who have experienced geriatric hip fractures. This randomized controlled trial aims to determine whether the supplement can reduce muscle loss measured by ultrasound of the rectus femoris muscle compared to standard nutritional counseling. The study is sponsored by NYU Langone Health and focuses on patients aged 65 years and older who require surgery for hip fractures. Participants in the experimental group will receive two packets of XR Carbohydrate Loading the evening before and the day of surgery, followed by twice daily doses of the XR Recovery Supplement for three weeks after surgery. The control group will receive standard nutritional counseling from a registered dietician during their hospital stay without the supplement. The study intervention starts at hospital admission and continues through the post-operative period. During the study, participants will be monitored for muscle loss using ultrasound at baseline and one year after surgery. Researchers will also assess secondary outcomes such as inpatient complications, wound healing issues, hospital length of stay, readmission rates, mortality, and physical function scores. The total participation includes inpatient monitoring and follow-up visits up to one year post-operation to evaluate these outcomes and overall recovery.
CONDITIONS
Brief Title
Nutritional Supplementation in Geriatric Hip Fractures
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female, aged 65 years or older
- Presenting with a geriatric hip fracture (femoral neck, intertrochanteric, or subtrochanteric) requiring surgical intervention
- Able to provide informed consent
- Expected to survive at least 6 months after surgery, with no terminal illness
You will not qualify if you...
- Pre-existing conditions that significantly impair mobility prior to injury
- Severe renal or liver impairment
- Active treatment with investigational drugs or participation in another clinical trial within the last 30 days
- Inability to tolerate oral nutritional supplementation due to gastrointestinal disorders
- Allergies to any components of the nutritional supplement being tested
Research Team
A
Abhishek Ganta, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here